Sino Biopharmaceutical Ltd - Diluted Average Shares

Sino Biopharmaceutical Ltd's Fiscal Year is From January To December - All Figures are in Billions.

The item "Diluted-Average-Shares" stands at 71.33 Billion for the trailing twelve months (TTM) period ending 06/30/2025.

Sino Biopharmaceutical Ltd's second quarter result of 18.03 Billion for the item "Diluted Average Shares" represents no change compared to it's first quarter result.

Also, Sino Biopharmaceutical Ltd's second quarter result of 18.03 Billion for the item "Diluted Average Shares" represents an increase of 5.18 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sino Biopharmaceutical Ltd's second quarter result of 71.33 Billion for the item "Diluted Average Shares" represents an increase of 1.26 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -2.27 percent compared to the value the year prior.
The 1 year change in percent is -2.27.
The 3 year change in percent is -7.13.
The 5 year change in percent is -5.52.
The 10 year change in percent is 6.92.

The Serie's long term average value is 70.55 Billion. It's latest available value, on 06/30/2025, is 1.10 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2011, to it's latest available value, on 06/30/2025, is +42.17%.
The Serie's change in percent from it's maximum value, on 12/31/2021, to it's latest available value, on 06/30/2025, is -7.53%.